Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GELTAMO/GETH Study.
Transplant Cell Ther
; 29(12): 747.e1-747.e10, 2023 Dec.
Article
in En
| MEDLINE
| ID: mdl-37659694
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, B-Cell
/
Hematopoietic Stem Cell Transplantation
/
Receptors, Chimeric Antigen
/
Lymphoma
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
Transplant Cell Ther
Year:
2023
Document type:
Article